Roman Butler Fullerton & Co’s Medtronic MDT Stock Holding History

Roman Butler Fullerton & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,593	Closed	-$233K	–	195
2023 Q1	$233K	Buy	+2,593	New	+$211K	0.12%	174
2022 Q2	–	Sell	-2,227	Closed	-$247K	–	189
2022 Q1	$247K	Buy	+2,227	New	+$235K	0.11%	173
2021 Q4	–	Sell	-2,164	Closed	-$261K	–	183
2021 Q3	$261K	Buy	2,164 +11	+0.5%	+$1.42K	0.12%	164
2021 Q2	$267K	Buy	2,153 +9	+0.4%	+$1.13K	0.13%	160
2021 Q1	$270K	Buy	2,144 +72	+3%	+$8.44K	0.14%	165
2020 Q4	$243K	Buy	2,072 +10	+0.5%	+$1.1K	0.14%	153
2020 Q3	$214K	Buy	+2,062	New	+$207K	0.14%	149
2020 Q1	–	Sell	-1,924	Closed	-$218K	–	157
2019 Q4	$218K	Buy	1,924 +9	+0.5%	+$988	0.14%	157
2019 Q3	$208K	Buy	+1,915	New	+$200K	0.14%	160

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Roman Butler Fullerton & Co's MDT Position: Q2 2023 in Review

Roman Butler Fullerton & Co sold out of Medtronic (MDT) in Q2 2023, closing a stake of 2,593 shares — an estimated $233K sold.

Roman Butler Fullerton & Co first reported a position in MDT in Q3 2019 and held it in 9 quarters. The position peaked at $270K in Q1 2021. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Roman Butler Fullerton & Co reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
Roman Butler Fullerton & Co sold 2,593 Medtronic shares in Q2 2023, an estimated $233K.
Roman Butler Fullerton & Co first reported a position in Medtronic in Q3 2019 and held it in 9 quarters.
Roman Butler Fullerton & Co's Medtronic position peaked at $270K in Q1 2021.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2023, filed 25 Jul 2023.